Balu Forge Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 10:24 am

Competitors of Balu Forge Industries Ltd

All Competitor Stocks of Balu Forge Industries Ltd

Quarterly Result

Last Updated: August 19, 2025, 10:45 pm

Below is a detailed analysis of the quarterly data for Balu Forge Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 233.00 Cr.. The value appears to be declining and may need further review. It has decreased from 270.00 Cr. (Mar 2025) to 233.00 Cr., marking a decrease of 37.00 Cr..
• For Expenses, as of Jun 2025, the value is 161.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 195.00 Cr. (Mar 2025) to 161.00 Cr., marking a decrease of 34.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 72.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Mar 2025) to 72.00 Cr., marking a decrease of 3.00 Cr..
• For OPM %, as of Jun 2025, the value is 31.00%. The value appears strong and on an upward trend. It has increased from 28.00% (Mar 2025) to 31.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 70.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 70.00 Cr., marking a decrease of 4.00 Cr..
• For Tax %, as of Jun 2025, the value is 19.00%. The value appears to be increasing, which may not be favorable. It has increased from 15.00% (Mar 2025) to 19.00%, marking an increase of 4.00%.
• For Net Profit, as of Jun 2025, the value is 57.00 Cr.. The value appears to be declining and may need further review. It has decreased from 63.00 Cr. (Mar 2025) to 57.00 Cr., marking a decrease of 6.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 5.09. The value appears to be declining and may need further review. It has decreased from 5.73 (Mar 2025) to 5.09, marking a decrease of 0.64.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:49 am

Growth

Last Updated: September 5, 2025, 2:36 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Balu Forge Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 19.24. This value is within the healthy range. It has increased from 9.80 (Mar 24) to 19.24, marking an increase of 9.44.
• For Diluted EPS (Rs.), as of Mar 25, the value is 18.38. This value is within the healthy range. It has increased from 9.74 (Mar 24) to 18.38, marking an increase of 8.64.
• For Cash EPS (Rs.), as of Mar 25, the value is 18.71. This value is within the healthy range. It has increased from 9.33 (Mar 24) to 18.71, marking an increase of 9.38.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 95.08. It has increased from 53.90 (Mar 24) to 95.08, marking an increase of 41.18.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 95.08. It has increased from 53.90 (Mar 24) to 95.08, marking an increase of 41.18.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 83.38. It has increased from 54.57 (Mar 24) to 83.38, marking an increase of 28.81.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 24.22. This value is within the healthy range. It has increased from 12.63 (Mar 24) to 24.22, marking an increase of 11.59.
• For PBIT / Share (Rs.), as of Mar 25, the value is 23.91. This value is within the healthy range. It has increased from 12.43 (Mar 24) to 23.91, marking an increase of 11.48.
• For PBT / Share (Rs.), as of Mar 25, the value is 22.93. This value is within the healthy range. It has increased from 11.10 (Mar 24) to 22.93, marking an increase of 11.83.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 18.40. This value is within the healthy range. It has increased from 9.13 (Mar 24) to 18.40, marking an increase of 9.27.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 18.40. This value is within the healthy range. It has increased from 9.13 (Mar 24) to 18.40, marking an increase of 9.27.
• For PBDIT Margin (%), as of Mar 25, the value is 29.04. This value is within the healthy range. It has increased from 23.13 (Mar 24) to 29.04, marking an increase of 5.91.
• For PBIT Margin (%), as of Mar 25, the value is 28.68. This value exceeds the healthy maximum of 20. It has increased from 22.77 (Mar 24) to 28.68, marking an increase of 5.91.
• For PBT Margin (%), as of Mar 25, the value is 27.49. This value is within the healthy range. It has increased from 20.33 (Mar 24) to 27.49, marking an increase of 7.16.
• For Net Profit Margin (%), as of Mar 25, the value is 22.07. This value exceeds the healthy maximum of 10. It has increased from 16.73 (Mar 24) to 22.07, marking an increase of 5.34.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 22.07. This value exceeds the healthy maximum of 20. It has increased from 16.73 (Mar 24) to 22.07, marking an increase of 5.34.
• For Return on Networth / Equity (%), as of Mar 25, the value is 19.35. This value is within the healthy range. It has increased from 16.94 (Mar 24) to 19.35, marking an increase of 2.41.
• For Return on Capital Employeed (%), as of Mar 25, the value is 24.65. This value is within the healthy range. It has increased from 22.02 (Mar 24) to 24.65, marking an increase of 2.63.
• For Return On Assets (%), as of Mar 25, the value is 16.27. This value is within the healthy range. It has increased from 13.14 (Mar 24) to 16.27, marking an increase of 3.13.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 24) to 0.01, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.08 (Mar 24) to 0.03, marking a decrease of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.94. It has decreased from 1.03 (Mar 24) to 0.94, marking a decrease of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 3.19. This value exceeds the healthy maximum of 3. It has decreased from 3.69 (Mar 24) to 3.19, marking a decrease of 0.50.
• For Quick Ratio (X), as of Mar 25, the value is 2.64. This value exceeds the healthy maximum of 2. It has decreased from 3.02 (Mar 24) to 2.64, marking a decrease of 0.38.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.48. This value is within the healthy range. It has decreased from 6.88 (Mar 24) to 6.48, marking a decrease of 0.40.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 24.48. This value is within the healthy range. It has increased from 9.50 (Mar 24) to 24.48, marking an increase of 14.98.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 19.61. This value is within the healthy range. It has increased from 7.87 (Mar 24) to 19.61, marking an increase of 11.74.
• For Enterprise Value (Cr.), as of Mar 25, the value is 7,009.40. It has increased from 2,056.42 (Mar 24) to 7,009.40, marking an increase of 4,952.98.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.59. This value exceeds the healthy maximum of 3. It has increased from 3.67 (Mar 24) to 7.59, marking an increase of 3.92.
• For EV / EBITDA (X), as of Mar 25, the value is 26.13. This value exceeds the healthy maximum of 15. It has increased from 15.88 (Mar 24) to 26.13, marking an increase of 10.25.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.65. This value exceeds the healthy maximum of 3. It has increased from 3.75 (Mar 24) to 7.65, marking an increase of 3.90.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 6.71. This value exceeds the healthy maximum of 3. It has increased from 3.79 (Mar 24) to 6.71, marking an increase of 2.92.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.65. This value exceeds the healthy maximum of 3. It has increased from 3.75 (Mar 24) to 7.65, marking an increase of 3.90.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness